
According to a report from Watoday on November 9, despite an estimated one million Australians using e-cigarettes, in a plan implemented by the federal government to include e-cigarettes as pharmacy products to combat the black market, only 3,500 sales were made in the first month.
Australia has approximately 5800 pharmacies nationwide, but data shows that thousands of them do not dispense any e-cigarette products on prescription. The federal government's initial policy analysis assumed that once illegal products are harder to obtain, about 450,000 people will seek medical e-cigarette products.
However, many pharmacists have stated that they are unwilling to sell e-cigarettes due to moral reasons or because the process is too cumbersome. Illegal e-cigarettes are still widely available, but prices have soared to 40 to 60 Australian dollars per device as retailers increase prices to compensate for higher penalties.
Last week, officials at a Senate estimates hearing stated that they currently do not track how many pharmacies are selling e-cigarettes. Chief Medical Officer Tony Lawler said that obtaining a definitive answer is actually quite difficult.
Health Department official Chris Bedford provided data on the sale of e-cigarette products by pharmacies following patient consultations. He stated that the total number of these sales across Australia reached 3,500, and pharmacists are able to dispense multiple e-cigarette products based on notification, leading to patients coming in and engaging in conversations.
Anne Ruston, the Health spokesperson for the opposition party, stated that the number of e-cigarettes sold by pharmacies last month only accounted for a small fraction of estimated e-cigarette users in Australia.
"We know that most pharmacists do not want to become tobacco merchants, as clearly reflected in the department's statistics."
Due to e-cigarette products not being included in Australia's registered therapeutic goods list, pharmacists must prescribe and sell unapproved products. This has made pharmacists cautious about supplying e-cigarettes. Data from the pharmacy industry shows that the majority of people are not willing to stock e-cigarettes, with a survey finding that 86% of pharmacies do not stock them.
Richard Lee, CEO of pharmaceutical company Liber Pharmaceuticals, stated that despite a slow start, the pharmacy's e-cigarette program is progressing within a reasonable range. The slow progress is partially due to the timing of the introduction of new regulations and the implementation phase. Lee expects pharmacies to gradually adapt to the new regulations and achieve significant growth within the next three to six months.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com